Emzotamig
Based on 1 Customer Validation
Emzotamig is a bispecific antibody targeting TNFRSF17 and NCR1. Emzotamig is promising for research of autoimmune diseases associated with TNF overexpression, such as rheumatoid arthritis and ankylosing spondylitis.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 97.35%
- CAS No.: 3037572-57-6
- 분자량:124.59 kDa
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
Isotype
VH-VH-CH1_VL-L-kappa_h-CH2-CH3
Species Reactivity
Human
IC50 & Target
TNFRSF17 & NCR1
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
VH-VH-CH1_VL-L-kappa_h-CH2-CH3
신청
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized BCMA/TNFRSF17 Protein, Human (HEK293, HY-P70827) can bind Emzotamig. The ED50 for this effect is 8.653 ng/mL. -
Immobilized NKp46/NCR1 Protein, Human (HEK293, HY-P77810) can bind Emzotamig. The ED50 for this effect is 172.2 ng/mL.
Chemical Information
-
CAS No. 3037572-57-6
-
Appearance Liquid
-
분자량 124.59 kDa
-
Color Colorless to light yellow
-
SMILES
N/A
-
선적
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
-
Data Sheet (269 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)